The Future Of
Epigenetics
Dedicated to the discovery and development of new treatments for
cancer based on reprogramming the epigenome.
Learn More >

About Us


EpiGenOnco, LLC is a biopharmaceutical company, headquartered in Philadelphia, dedicated to the discovery and development of new treatments for cancer based on reprogramming the epigenome…

Learn More

WHAT WE DO


advanced screening

We screen for and validate a compounds’ potential epigenetic activity

epigenetic activity

We’ve identified a new molecule that inhibits CDK9 and modulates the epigenome

molecular study

We study cellular and animal models of disease to identify and validate potential epigenetic targets.

genetic tools

We use these to understand the function of specific genes that encode epigenetic regulators

Drug Development

We advance leads into preclinical development & beyond in collaboration with 3rd party service providers

Our

LEADERSHIP


We have leading experts in the field of epigenetic therapy, oncology and drug development.

Our

mission


Our mission is to develop new treatments in the fight against cancer. We are tenaciously driven to discover and develop new drugs with a focus on reprogramming cancer cells by targeting an aberrant epigenome. In short, we aim to turn ground-breaking science into practical benefit to improve the lives of people around the world.